Industry: Medical Devices & Consumables
Published Date: 2025-08-05
Pages: 151 Pages
Report ld: 4848595
Request Sample
Customized Report
Capsule Gastrointestinal Endoscopic Devices Market Size(US$)

CAGR 2025-2031
18.6%
Market Size,2031
USD 1,421
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Capsule Gastrointestinal Endoscopic Devices market is projected to grow from US$ 437 million in 2024 to US$ 1421 million by 2031, at a CAGR of 18.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Capsule gastrointestinal endoscopic devices are an emerging medical diagnostic tool used to examine the internal structure of the gastrointestinal tract. These devices come in the form of swallowable capsules equipped with high-definition cameras, light sources, batteries, and wireless transmitters. Without the need for anesthesia, patients simply swallow the capsule, which captures images of the digestive tract as it naturally moves through the gastrointestinal system. The technology is non-invasive, safe, and comfortable, making it particularly suitable for patients who cannot tolerate traditional endoscopy, such as children, the elderly, or those with specific medical conditions. In recent years, advancements in artificial intelligence and image processing have expanded the potential applications of capsule endoscopy, particularly for early diagnosis of diseases such as gastrointestinal bleeding, inflammatory bowel disease, and tumor screening.
Capsule gastrointestinal endoscopic devices are an innovative diagnostic tool that has gained increasing attention and acceptance in recent years. These devices are primarily used for non-invasive examinations of the digestive system, valued for their comfort, convenience, and accuracy. Currently, the market is concentrated in developed regions due to advanced medical infrastructure and higher patient affordability. However, as medical technology becomes more accessible and primary healthcare services improve, emerging markets are beginning to demonstrate significant potential
In the future, the integration of artificial intelligence and data analytics will make capsule gastrointestinal endoscopic devices more intelligent, enabling real-time diagnostics, remote monitoring, and more efficient data processing. This will enhance diagnostic efficiency while reducing the workload of healthcare professionals. Additionally, trends toward miniaturization and modular design will offer new possibilities, making the devices more portable and applicable to a broader range of clinical scenarios.
Key drivers of market growth include the rising demand for early disease screening, aging populations, and increasing prevalence of chronic diseases. Policy support and the adoption of innovative medical technologies also provide a robust foundation for market expansion. However, challenges such as high device costs, insufficient training for professionals, and limited acceptance of advanced medical technologies in certain regions remain significant barriers. Furthermore, complex regulations and approval processes may delay the introduction of new technologies to the market.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Capsule Gastrointestinal Endoscopic Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Capsule Gastrointestinal Endoscopic Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Capsule Gastrointestinal Endoscopic Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Capsule Gastrointestinal Endoscopic Devices Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Capsule Colonoscopy
1.2.3 Capsule Gastroscopy
1.3 Market Segmentation by Application
1.3.1 Global Capsule Gastrointestinal Endoscopic Devices Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Physical Examination Center
1.3.3 Hospital
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Capsule Gastrointestinal Endoscopic Devices Revenue Estimates and Forecasts 2020-2031
2.2 Global Capsule Gastrointestinal Endoscopic Devices Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Capsule Gastrointestinal Endoscopic Devices Sales Estimates and Forecasts 2020-2031
2.4 Global Capsule Gastrointestinal Endoscopic Devices Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Capsule Gastrointestinal Endoscopic Devices Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Capsule Gastrointestinal Endoscopic Devices Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Capsule Colonoscopy Market Size by Manufacturers
3.5.2 Capsule Gastroscopy Market Size by Manufacturers
3.6 Global Capsule Gastrointestinal Endoscopic Devices Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Capsule Gastrointestinal Endoscopic Devices Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Capsule Gastrointestinal Endoscopic Devices Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Capsule Gastrointestinal Endoscopic Devices Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Capsule Gastrointestinal Endoscopic Devices Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Capsule Gastrointestinal Endoscopic Devices Sales and Revenue by Type (2020-2031)
6.4 North America Capsule Gastrointestinal Endoscopic Devices Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Capsule Gastrointestinal Endoscopic Devices Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Capsule Gastrointestinal Endoscopic Devices Sales and Revenue by Type (2020-2031)
7.4 Europe Capsule Gastrointestinal Endoscopic Devices Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Capsule Gastrointestinal Endoscopic Devices Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Capsule Gastrointestinal Endoscopic Devices Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Capsule Gastrointestinal Endoscopic Devices Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Capsule Gastrointestinal Endoscopic Devices Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Capsule Gastrointestinal Endoscopic Devices Sales and Revenue by Type (2020-2031)
9.4 Central and South America Capsule Gastrointestinal Endoscopic Devices Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Capsule Gastrointestinal Endoscopic Devices Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Capsule Gastrointestinal Endoscopic Devices Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Capsule Gastrointestinal Endoscopic Devices Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Capsule Gastrointestinal Endoscopic Devices Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Chongqing Jinshan
11.1.1 Chongqing Jinshan Corporation Information
11.1.2 Chongqing Jinshan Business Overview
11.1.3 Chongqing Jinshan Capsule Gastrointestinal Endoscopic Devices Product Models, Descriptions and Specifications
11.1.4 Chongqing Jinshan Capsule Gastrointestinal Endoscopic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Chongqing Jinshan Capsule Gastrointestinal Endoscopic Devices Sales by Product in 2024
11.1.6 Chongqing Jinshan Capsule Gastrointestinal Endoscopic Devices Sales by Application in 2024
11.1.7 Chongqing Jinshan Capsule Gastrointestinal Endoscopic Devices Sales by Geographic Area in 2024
11.1.8 Chongqing Jinshan Capsule Gastrointestinal Endoscopic Devices SWOT Analysis
11.1.9 Chongqing Jinshan Recent Developments
11.2 Medtronic
11.2.1 Medtronic Corporation Information
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Capsule Gastrointestinal Endoscopic Devices Product Models, Descriptions and Specifications
11.2.4 Medtronic Capsule Gastrointestinal Endoscopic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Medtronic Capsule Gastrointestinal Endoscopic Devices Sales by Product in 2024
11.2.6 Medtronic Capsule Gastrointestinal Endoscopic Devices Sales by Application in 2024
11.2.7 Medtronic Capsule Gastrointestinal Endoscopic Devices Sales by Geographic Area in 2024
11.2.8 Medtronic Capsule Gastrointestinal Endoscopic Devices SWOT Analysis
11.2.9 Medtronic Recent Developments
11.3 Olympus
11.3.1 Olympus Corporation Information
11.3.2 Olympus Business Overview
11.3.3 Olympus Capsule Gastrointestinal Endoscopic Devices Product Models, Descriptions and Specifications
11.3.4 Olympus Capsule Gastrointestinal Endoscopic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Olympus Capsule Gastrointestinal Endoscopic Devices Sales by Product in 2024
11.3.6 Olympus Capsule Gastrointestinal Endoscopic Devices Sales by Application in 2024
11.3.7 Olympus Capsule Gastrointestinal Endoscopic Devices Sales by Geographic Area in 2024
11.3.8 Olympus Capsule Gastrointestinal Endoscopic Devices SWOT Analysis
11.3.9 Olympus Recent Developments
11.4 IntroMedic
11.4.1 IntroMedic Corporation Information
11.4.2 IntroMedic Business Overview
11.4.3 IntroMedic Capsule Gastrointestinal Endoscopic Devices Product Models, Descriptions and Specifications
11.4.4 IntroMedic Capsule Gastrointestinal Endoscopic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 IntroMedic Capsule Gastrointestinal Endoscopic Devices Sales by Product in 2024
11.4.6 IntroMedic Capsule Gastrointestinal Endoscopic Devices Sales by Application in 2024
11.4.7 IntroMedic Capsule Gastrointestinal Endoscopic Devices Sales by Geographic Area in 2024
11.4.8 IntroMedic Capsule Gastrointestinal Endoscopic Devices SWOT Analysis
11.4.9 IntroMedic Recent Developments
11.5 CapsoVision
11.5.1 CapsoVision Corporation Information
11.5.2 CapsoVision Business Overview
11.5.3 CapsoVision Capsule Gastrointestinal Endoscopic Devices Product Models, Descriptions and Specifications
11.5.4 CapsoVision Capsule Gastrointestinal Endoscopic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 CapsoVision Capsule Gastrointestinal Endoscopic Devices Sales by Product in 2024
11.5.6 CapsoVision Capsule Gastrointestinal Endoscopic Devices Sales by Application in 2024
11.5.7 CapsoVision Capsule Gastrointestinal Endoscopic Devices Sales by Geographic Area in 2024
11.5.8 CapsoVision Capsule Gastrointestinal Endoscopic Devices SWOT Analysis
11.5.9 CapsoVision Recent Developments
11.6 Shenzhen Jifu Medical Technology
11.6.1 Shenzhen Jifu Medical Technology Corporation Information
11.6.2 Shenzhen Jifu Medical Technology Business Overview
11.6.3 Shenzhen Jifu Medical Technology Capsule Gastrointestinal Endoscopic Devices Product Models, Descriptions and Specifications
11.6.4 Shenzhen Jifu Medical Technology Capsule Gastrointestinal Endoscopic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Shenzhen Jifu Medical Technology Recent Developments
11.7 Ankon Technologies
11.7.1 Ankon Technologies Corporation Information
11.7.2 Ankon Technologies Business Overview
11.7.3 Ankon Technologies Capsule Gastrointestinal Endoscopic Devices Product Models, Descriptions and Specifications
11.7.4 Ankon Technologies Capsule Gastrointestinal Endoscopic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Ankon Technologies Recent Developments
11.8 Shangxian Minimal Invasive
11.8.1 Shangxian Minimal Invasive Corporation Information
11.8.2 Shangxian Minimal Invasive Business Overview
11.8.3 Shangxian Minimal Invasive Capsule Gastrointestinal Endoscopic Devices Product Models, Descriptions and Specifications
11.8.4 Shangxian Minimal Invasive Capsule Gastrointestinal Endoscopic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Shangxian Minimal Invasive Recent Developments
11.9 Hangzhou Hitron Medical Equipment
11.9.1 Hangzhou Hitron Medical Equipment Corporation Information
11.9.2 Hangzhou Hitron Medical Equipment Business Overview
11.9.3 Hangzhou Hitron Medical Equipment Capsule Gastrointestinal Endoscopic Devices Product Models, Descriptions and Specifications
11.9.4 Hangzhou Hitron Medical Equipment Capsule Gastrointestinal Endoscopic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Hangzhou Hitron Medical Equipment Recent Developments
11.10 Beijing Richen-Force
11.10.1 Beijing Richen-Force Corporation Information
11.10.2 Beijing Richen-Force Business Overview
11.10.3 Beijing Richen-Force Capsule Gastrointestinal Endoscopic Devices Product Models, Descriptions and Specifications
11.10.4 Beijing Richen-Force Capsule Gastrointestinal Endoscopic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Beijing Richen-Force Recent Developments
11.11 Guangzhou Side Medical Technology
11.11.1 Guangzhou Side Medical Technology Corporation Information
11.11.2 Guangzhou Side Medical Technology Business Overview
11.11.3 Guangzhou Side Medical Technology Capsule Gastrointestinal Endoscopic Devices Product Models, Descriptions and Specifications
11.11.4 Guangzhou Side Medical Technology Capsule Gastrointestinal Endoscopic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Guangzhou Side Medical Technology Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Capsule Gastrointestinal Endoscopic Devices Industry Chain
12.2 Capsule Gastrointestinal Endoscopic Devices Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Capsule Gastrointestinal Endoscopic Devices Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Capsule Gastrointestinal Endoscopic Devices Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Capsule Gastrointestinal Endoscopic Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Capsule Gastrointestinal Endoscopic Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Capsule Gastrointestinal Endoscopic Devices market is projected to grow from US$ 510 million in 2025 to US$ 1660 million by 2032, at a CAGR of 18.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 152
USD 4900.00
(Single User License)
The global Capsule Gastrointestinal Endoscopic Devices market size was US$ 510 million in 2025 and is forecast to reach a readjusted size of US$ 1660 million by 2032 with a CAGR of 18.6% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 96
USD 4250.00
(Single User License)
The global market for Capsule Gastrointestinal Endoscopic Devices was estimated to be worth US$ 510 million in 2025 and is projected to reach US$ 1660 million, growing at a CAGR of 18.6% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 121
USD 3950.00
(Single User License)
The global Capsule Gastrointestinal Endoscopic Devices market was valued at US$ 510 million in 2025 and is anticipated to reach US$ 1660 million by 2032, at a CAGR of 18.6% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 122
USD 2900.00
(Single User License)
The global Capsule Gastrointestinal Endoscopic Devices market size was US$ 437 million in 2024 and is forecast to a readjusted size of US$ 1421 million by 2031 with a CAGR of 18.6% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 100
USD 4250.00
(Single User License)
The global market for Capsule Gastrointestinal Endoscopic Devices was estimated to be worth US$ 437 million in 2024 and is forecast to a readjusted size of US$ 1421 million by 2031 with a CAGR of 18.6% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 113
USD 3950.00
(Single User License)
The global market for Capsule Gastrointestinal Endoscopic Devices was valued at US$ 437 million in the year 2024 and is projected to reach a revised size of US$ 1421 million by 2031, growing at a CAGR of 18.6% during the forecast period.
Published Date: 2025-03-10
Pages: 95
USD 2900.00
(Single User License)
The global Capsule Gastrointestinal Endoscopic Devices revenue was US$ 364 million in 2023 and is forecast to a readjusted size of US$ 1217 million by 2030 with a CAGR of 18.6% during the review period (2024-2030).
Published Date: 2025-01-01
Pages: 121
USD 4350.00
(Single User License)
Valued at US$ 437 million in 2024, the global Capsule Gastrointestinal Endoscopic Devices market is forecast to reach US$ 1217 million by 2030, at a CAGR of 18.6% during the forecast period.
Published Date: 2025-01-01
Pages: 160
USD 4900.00
(Single User License)
The global market for Capsule Gastrointestinal Endoscopic Devices was valued at US$ 364 million in the year 2023 and is projected to reach a revised size of US$ 1217 million by 2030, growing at a CAGR of 18.6% during the forecast period.
Published Date: 2025-01-01
Pages: 94
USD 2900.00
(Single User License)
The global Capsule Gastrointestinal Endoscopic Devices market is projected to grow from US$ 510 million in 2025 to US$ 1660 million by 2032, at a CAGR of 18.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 152
The global Capsule Gastrointestinal Endoscopic Devices market size was US$ 510 million in 2025 and is forecast to reach a readjusted size of US$ 1660 million by 2032 with a CAGR of 18.6% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 96
The global market for Capsule Gastrointestinal Endoscopic Devices was estimated to be worth US$ 510 million in 2025 and is projected to reach US$ 1660 million, growing at a CAGR of 18.6% from 2026 to 2032.
Published: 2026-01-08
Pages: 121
The global Capsule Gastrointestinal Endoscopic Devices market was valued at US$ 510 million in 2025 and is anticipated to reach US$ 1660 million by 2032, at a CAGR of 18.6% from 2026 to 2032.
Published: 2026-01-08
Pages: 122
The global Capsule Gastrointestinal Endoscopic Devices market size was US$ 437 million in 2024 and is forecast to a readjusted size of US$ 1421 million by 2031 with a CAGR of 18.6% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 100
The global market for Capsule Gastrointestinal Endoscopic Devices was estimated to be worth US$ 437 million in 2024 and is forecast to a readjusted size of US$ 1421 million by 2031 with a CAGR of 18.6% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 113
The global market for Capsule Gastrointestinal Endoscopic Devices was valued at US$ 437 million in the year 2024 and is projected to reach a revised size of US$ 1421 million by 2031, growing at a CAGR of 18.6% during the forecast period.
Published: 2025-03-10
Pages: 95
The global Capsule Gastrointestinal Endoscopic Devices revenue was US$ 364 million in 2023 and is forecast to a readjusted size of US$ 1217 million by 2030 with a CAGR of 18.6% during the review period (2024-2030).
Published: 2025-01-01
Pages: 121
Valued at US$ 437 million in 2024, the global Capsule Gastrointestinal Endoscopic Devices market is forecast to reach US$ 1217 million by 2030, at a CAGR of 18.6% during the forecast period.
Published: 2025-01-01
Pages: 160
The global market for Capsule Gastrointestinal Endoscopic Devices was valued at US$ 364 million in the year 2023 and is projected to reach a revised size of US$ 1217 million by 2030, growing at a CAGR of 18.6% during the forecast period.
Published: 2025-01-01
Pages: 94
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now